BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 36461613)

  • 1. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
    Kang H; Ma D; Zhang J; Zhao J; Yang M
    BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
    Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
    Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.
    Wang B; Cai Y; Li X; Kong Y; Fu H; Zhou J
    Cell Cycle; 2021 Dec; 20(24):2607-2618. PubMed ID: 34850664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
    Wang M; Liao Q; Zou P
    Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
    Wu Q; Jiang J
    Mol Biotechnol; 2022 Sep; 64(9):970-983. PubMed ID: 35275356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163.
    Qiu C; Li C; Zheng Q; Fang S; Xu J; Wang H; Guo H
    Bioengineered; 2022 May; 13(5):11987-12002. PubMed ID: 35603556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
    Ying K; Wang L; Long G; Lian C; Chen Z; Lin W
    Cell Biol Int; 2020 Dec; 44(12):2438-2449. PubMed ID: 32808728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.
    Wei Y; Wei L; Li J; Ma Z; Zhang Q; Han Z; Li S
    Cancer Med; 2020 Oct; 9(19):7205-7217. PubMed ID: 32762035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ZFPM2-AS1 is involved in lung adenocarcinoma via miR-511-3p/AFF4 pathway.
    Li J; Ge J; Yang Y; Liu B; Zheng M; Shi R
    J Cell Biochem; 2020 Mar; 121(3):2534-2542. PubMed ID: 31692047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
    Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
    Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
    Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
    Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
    Liu J; Pan C; Lu R; Zhang S
    Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.